Loading...
01/11 11:50
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with a 75%-76% YoY revenue growth and a consistent EBITDA margin of 32%. The company is focusing on margin expansion, debt reduction, and integrated platform development. The Q&A highlights optimism about future growth, particularly in ARR and new pricing models. While there were some vague responses, the overall sentiment, including a robust market strategy and positive financial metrics, suggests a positive stock price movement. Given the market cap, the stock is likely to react positively, but not extremely, suggesting a 2%-8% increase.
Revenue $205.1 million, a 77% year-on-year growth. The growth was driven by the integration of acquisitions and strong performance in the hedge fund market.
Annualized Recurring Revenue (ARR) $807.5 million, up 77% year-over-year. This reflects the durability and predictability of the business model, with organic ARR improving to $534.4 million.
Adjusted EBITDA $70.7 million, up from $58.3 million in Q2 and an 84% year-over-year growth. The margin improved to 34.5% from 32.1% in Q2, driven by operational efficiencies and integration of acquisitions.
Gross Revenue Retention (GRR) 98%, consistent with historical performance, attributed to strong client retention and operational excellence.
Gross Margin 78.5%, flat year-over-year but achieved earlier than the 2027 target, driven by integration efficiencies and the use of Generative AI.
Net Revenue Retention (NRR) 108%, slightly down from 110% in Q2 due to lower contributions from AUM growth and asset-based upsells.
Core Clearwater Growth 21% year-to-date over last year, showing resilience and strong performance.
Enfusion Growth 12% expected growth for the year, with continued booking execution in Q2 and Q3.
EBITDA Margin 34.5%, a 140 basis point improvement compared to Q3 2024, reflecting efficiency gains and successful integration of lower-margin businesses.
Generative AI: CWAN has integrated Generative AI into its operations, achieving significant gross margin improvements. The platform hosts over 800 AI agents, managing $10 trillion in institutional assets. Clients have seen 90% reductions in manual reconciliation, 80% faster regulatory reporting, and 50% faster financial close cycles.
Integrated Platform Development: CWAN is developing a single security master, a comprehensive data platform, a single interaction layer, and a single interchange layer, expected to launch in H2 2026 and early 2027.
Total Addressable Market (TAM): CWAN's TAM has grown to $23 billion, driven by globalization, alternative assets, and regulatory needs. The company is leveraging its competitive position to capture market share.
Geographic Expansion: CWAN has expanded its global capabilities, with wins in North America, Europe, Asia, and Latin America. Notable clients include Texas Treasury Safekeeping Trust and the Latin American Reserve Fund.
Revenue and ARR Growth: Q3 revenue reached $205.1 million, a 77% YoY growth. ARR also grew 77% YoY to $807.5 million, showcasing business durability.
Margin Improvements: Gross margin reached 78.5%, hitting 2027 targets early. Adjusted EBITDA margin improved to 34.5%, driven by operational efficiencies and GenAI adoption.
Acquisitions and Integration: CWAN successfully integrated Enfusion, Beacon, and Bistro, achieving 77% revenue growth and 84% EBITDA growth YoY. The acquisitions expanded TAM and enhanced cross-selling opportunities.
Cross-Selling Initiatives: Cross-selling efforts have begun, with a 70% increase in bookings for core cross-sell modules. This is expected to drive growth in Q4 2025 and beyond.
Market Conditions: The company faces challenges from the competitive landscape, despite its strong positioning. The market's demand environment may fluctuate, impacting growth opportunities.
Regulatory Hurdles: The increasing complexity related to regulatory and compliance needs poses a challenge for the company to continuously adapt its technology and solutions.
Supply Chain Disruptions: No explicit mention of supply chain disruptions was made in the transcript.
Economic Uncertainties: Economic conditions, such as fluctuations in AUM (Assets Under Management) growth, have impacted net revenue retention rates, which could affect financial performance.
Strategic Execution Risks: The integration of acquired businesses (Enfusion, Beacon, Bistro) presents risks, including achieving margin synergies and aligning commercial models. Additionally, the company’s ambitious plans for Generative AI and platform unification by 2026-2027 carry execution risks.
Revenue Projections: For Q4 2025, total revenue is expected to be $216 million to $217 million, representing a year-over-year growth rate of 71% to 72%. For the full year 2025, total revenue is projected to be between $730 million and $731 million, representing a year-over-year growth rate of approximately 62%.
EBITDA Projections: Fourth quarter EBITDA is expected to be $73 million, representing an adjusted EBITDA margin of 34%. Full year 2025 EBITDA is projected to be $247 million, with a full year margin of 34%, which is 180 basis points better than 2024 margins.
Growth Expectations: The company expects cross-selling to power growth in Q4 2025 and in 2026 and beyond. Growth plans include expanding in insurance, asset management, and asset owners, as well as executing opportunities across geographies, markets, and products.
Generative AI Impact: Generative AI is expected to continue driving gross margin improvements and operational efficiencies. The company plans to bring new integrated AI-driven solutions to market in H2 2026 and early 2027.
Platform Development: The company is working on building an integrated, open, modular, and extensible front-to-back platform, with key components expected to be launched in H2 2026 and early 2027.
Market Position and TAM: The total addressable market (TAM) has grown to approximately $23 billion, with significant opportunities across geographies and markets. The company aims to leverage its competitive position to capture market share.
Share Repurchase: The company repurchased more than 800,000 shares of CWAN stock during the quarter. This was enabled by strong EBITDA performance, which provided the financial flexibility to execute the share buyback program.
The earnings call reveals strong financial performance with a 75%-76% YoY revenue growth and a consistent EBITDA margin of 32%. The company is focusing on margin expansion, debt reduction, and integrated platform development. The Q&A highlights optimism about future growth, particularly in ARR and new pricing models. While there were some vague responses, the overall sentiment, including a robust market strategy and positive financial metrics, suggests a positive stock price movement. Given the market cap, the stock is likely to react positively, but not extremely, suggesting a 2%-8% increase.
The earnings call shows strong financial performance with significant revenue growth, improved margins, and increased cash flow. Product innovation and geographic expansion plans are promising, though they carry some risks. The Q&A section doesn't highlight major concerns, and the market cap suggests moderate volatility. Despite regulatory and competition risks, the overall sentiment is positive due to strong financial metrics and optimistic guidance, suggesting a stock price increase of 2% to 8%.
The earnings call highlights strong financial performance with a 21% YoY revenue growth projection for Q2 2025 and a 59-61% full-year growth. The Bloomberg partnership and strategic acquisitions support market expansion. The Q&A section reveals positive sentiment, with expectations for accelerated growth and successful cross-selling. Despite management's lack of specificity on some points, the overall outlook is optimistic, especially given the market cap of $4 billion, suggesting a positive stock price movement of 2-8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
